Tag #Adverse Events

What is the immediate impact of the reported adverse events related to the chikungunya vaccine on the vaccination campaign in Réunion and Mayotte?

Following three serious adverse events, including one death, in individuals over 65 receiving the Ixchiq chikungunya vaccine in Réunion Island and Mayotte, authorities have suspended vaccinations for this age group. The vaccine's use remains authorized for those aged 18-64 with comorbidities. This decision comes as the chikungunya epidemic has claimed nine lives in Réunion.